Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain
- PMID: 11803071
- DOI: 10.1016/s0264-410x(01)00438-8
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain
Abstract
Data from routine surveillance during two mass immunisation campaigns (MIC) with Measles-mumps-rubella (MMR)vaccine using Leningrad-Zagreb mumps strain in two states in Brazil were analysed to estimate the risk of vaccine-related meningitis and mumps. Increase in the incidence of the two diseases was observed in both states, 3 weeks after the vaccination campaigns. The estimated number of doses applied per one case of vaccine-related meningitis ranged from 6199 (95% CI: 4854-8058) to 19,247 (95% CI: 12,648-29,513) depending on the diagnostic criteria used and state. It was 300 doses (95% CI: 286-317) for each case of mumps. The implications for vaccination policy are discussed.
Comment in
-
No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study.Vaccine. 2005 Nov 16;23(46-47):5286-8. doi: 10.1016/j.vaccine.2005.05.029. Epub 2005 Jun 13. Vaccine. 2005. PMID: 15985315
Similar articles
-
The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.Int J Epidemiol. 2002 Oct;31(5):978-82. doi: 10.1093/ije/31.5.978. Int J Epidemiol. 2002. PMID: 12435771
-
Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.Am J Epidemiol. 2000 Mar 1;151(5):524-30. doi: 10.1093/oxfordjournals.aje.a010239. Am J Epidemiol. 2000. PMID: 10707922
-
Aseptic meningitis after measles-mumps-rubella (MMR) vaccination.Br J Biomed Sci. 2016;73(2):84-6. doi: 10.1080/09674845.2016.1159047. Epub 2016 May 5. Br J Biomed Sci. 2016. PMID: 27181175 No abstract available.
-
A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine.Hum Vaccin Immunother. 2024 Dec 31;20(1):2302685. doi: 10.1080/21645515.2024.2302685. Epub 2024 Jan 18. Hum Vaccin Immunother. 2024. PMID: 38236022 Free PMC article. Review.
-
[Aseptic meningitis due to mumps vaccine. Case report and review of the literature].Rev Chilena Infectol. 2020 Dec;37(6):769-774. doi: 10.4067/S0716-10182020000600769. Rev Chilena Infectol. 2020. PMID: 33844819 Review. Spanish.
Cited by
-
In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.Vaccine. 2015 Aug 26;33(36):4586-93. doi: 10.1016/j.vaccine.2015.06.109. Epub 2015 Jul 15. Vaccine. 2015. PMID: 26187256 Free PMC article.
-
Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet.BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1472-698X-9-S1-S6. BMC Int Health Hum Rights. 2009. PMID: 19828064 Free PMC article.
-
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.Am J Public Health. 2004 Nov;94(11):1926-31. doi: 10.2105/ajph.94.11.1926. Am J Public Health. 2004. PMID: 15514229 Free PMC article.
-
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.Hum Vaccin Immunother. 2017 Jul 3;13(7):1523-1530. doi: 10.1080/21645515.2017.1302629. Epub 2017 Mar 31. Hum Vaccin Immunother. 2017. PMID: 28362563 Free PMC article. Clinical Trial.
-
Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.Int J Environ Res Public Health. 2018 Jul 31;15(8):1618. doi: 10.3390/ijerph15081618. Int J Environ Res Public Health. 2018. PMID: 30065192 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical